SVT Associates is a leading Ultra High Vacuum (UHV) and Molecular Beam Epitaxy equipment development and manufacturing company. SVTA also produces state-of-the-art III-V epitaxial materials and devices, in-situ monitoring tools, and system deposition components.
A leader in delivering semiconductor design software, intellectual property (IP), design for manufacturing (DFM) solutions and professional services that companies use to design systems-on-chips (SoCs) and electronic systems.
Systems and Materials Research Corporation (SMRC) specializes in materials and technology development for the purpose of commercialization. Areas of expertise include nanocomposite formulation/prototyping and nanocomposites/nanoputties/nanofluids.
T2 Biosystems is creating a new generation of lab-quality diagnostic tools. Its technology is based on superparamagnetic nanoparticles. NanoDx particles have a superparamagnetic metal core surrounded by a polymer layer decorated by multiple analyte-specific binding agents. This nanoparticle platform can be used with a variety of binding agents such as antibodies, nucleic acids and small molecules.
R&D company which develops new materials (polymers, carbons and ceramics), catalytic and sorbent-based chemical processes and military and aerospace components. Materials include fullerenes and carbon nanotubes. TDA is developing an exciting new class of nanomaterials, the metal-carbon nanoencapsulates, for use in medial and electronics applications.
Ted Pella, Inc ia a leading manufacturer of consumables, supplies, tools and specimen preparation equipment for all disciplines of microscopy and nanotechnology. Specialized in specimen mounts and holders for SEM, FIB, support films and grids for TEM, calibrations standards and sample storage.
Tellurex delivers high performance thermoelectric products to both large and small volume customers. The company performs primary research in chemical metallurgy in collaboration with major universities.
Tempo is focused on significantly improving the efficacy and safety profile of existing and new drugs employing advances in nanotechnology. The Company utilizes its proprietary Nanocell™ technology to develop multi-compartmental, nanoparticle-based therapeutics in which two drugs with varied release rates are packaged within a single nanoparticle.